Bladder Cancer Markers, Urine

Bladder Cancer Markers, Urine is a topic covered in the Davis's Lab & Diagnostic Tests.

To view the entire topic, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

Nursing Central

-- The first section of this topic is shown below --

Synonym/Acronym:
Nuclear matrix protein (NMP) 22, bladder tumor antigen (BTA), cytogenic marker for bladder cancer.

Rationale
To assist in diagnosing bladder cancer.

Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction. As appropriate, provide the required urine collection container and specimen collection instructions.

Normal Findings
Method: Enzyme immunoassay for NMP22 and BTA, fluorescence in situ hybridization (FISH) for cytogenic marker.

NMP22: Negative: Less than 6 units/mL, borderline: 6 to 10 units/mL, positive: greater than 10 units/mL.

BTA: Negative.

Cytogenic Marker: Negative.

Critical Findings and Potential Interventions

  • Bladder cancer

Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.

-- To view the remaining sections of this topic, please or purchase a subscription --